Skip to content

Application of RNA-SEQ in screening specific RNA in peripheral blood monocyte in patients with severe tuberculosis for early diagnosis of tuberculosis progression

Application of RNA-SEQ in screening specific RNA in peripheral blood monocyte in patients with severe tuberculosis for early diagnosis of tuberculosis progression

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032719
Enrollment
Unknown
Registered
2020-05-08
Start date
2020-04-30
Completion date
Unknown
Last updated
2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tuberculosis

Interventions

Gold Standard:Diagnostic criteria for tuberculosis(WS288-2017)
Index test:lncRNA,mRNA,cirRNA

Sponsors

Beijing Chest Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria (1) Severe secondary tuberculosis group: Diagnose patients with secondary tuberculosis according to "Diagnostic Criteria for Tuberculosis (WS288-2008)". Mycobacterium tuberculosis sputum was positive for acid-fast staining. The lesion occupies >= 3 lung fields, with holes or serious complications. The newly treated patients did not receive anti-tuberculosis treatment. (2) Mild secondary tuberculosis group: patients with secondary tuberculosis diagnosed according to "Diagnostic Criteria for Tuberculosis (WS288-2008)". The selected case was active pulmonary tuberculosis, and mycobacterium tuberculosis sputum was positive for acid-fast staining. The lesion occupies <= 2 lung fields. The newly treated patients did not receive anti-tuberculosis treatment.

Exclusion criteria

Exclusion criteria: 1. Patients younger than 18 years old; 2. Patients with malignant tumors; 3. Patients with immune system diseases or receiving immunotherapy; 4. Patients infected with HIV, hepatitis B and hepatitis C virus; 5. Patients with complications during pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
lncRNA;SEN, SPE, ACC, PPV, NPV, AUC of ROC;

Secondary

MeasureTime frame
mRNA;cirRNA;

Countries

China

Contacts

Public ContactLiu Qiuyue

Beijing Chest Hospital Affiliated to Capital Medical University

28195059@qq.com+86 10-89509052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026